Subhashis Banerjee, the Chief Medical Officer of $ARTV, sold 8,222 shares of the company on 08-27-2026 for an estimated $98,735. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.5% of their shares of this class of stock. Following this trade, they now own 142,047 shares of this class of $ARTV stock.
$ARTV Insider Trading Activity
$ARTV insiders have traded $ARTV stock on the open market 28 times in the past 6 months. Of those trades, 21 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ARTV stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA has made 19 purchases buying 8,636,021 shares for an estimated $92,620,145 and 0 sales.
- CORP. GC has made 2 purchases buying 1,432,291 shares for an estimated $16,499,992 and 0 sales.
- FRED ASLAN (Chief Executive Officer) sold 27,116 shares for an estimated $244,252
- SUBHASHIS BANERJEE (Chief Medical Officer) has made 0 purchases and 3 sales selling 15,688 shares for an estimated $167,270.
- JENNIFER BUSH (COO, CLO, Compliance Officer) sold 8,790 shares for an estimated $79,178
- CHRISTOPHER HORAN (Chief Tech Operations Officer) sold 7,002 shares for an estimated $63,072
- HEATHER RAYMON (SVP, Research and Development) sold 3,095 shares for an estimated $27,879
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ARTV Hedge Fund Activity
We have seen 60 institutional investors add shares of $ARTV stock to their portfolio, and 13 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. added 8,102,340 shares (+82.2%) to their portfolio in Q2 2026, for an estimated $78,592,698
- VIKING GLOBAL INVESTORS LP added 2,604,166 shares (+inf%) to their portfolio in Q2 2026, for an estimated $25,260,410
- BLACKSTONE INC. added 2,403,437 shares (+inf%) to their portfolio in Q2 2026, for an estimated $23,313,338
- CALIGAN PARTNERS LP added 1,736,111 shares (+inf%) to their portfolio in Q2 2026, for an estimated $16,840,276
- FRANKLIN RESOURCES INC added 1,476,896 shares (+283.8%) to their portfolio in Q2 2026, for an estimated $14,325,891
- SAMSARA BIOCAPITAL, LLC added 954,861 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,262,151
- BLUE OWL CAPITAL HOLDINGS LP added 874,542 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,483,057
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ARTV Price Targets
Multiple analysts have issued price targets for $ARTV recently. We have seen 4 analysts offer price targets for $ARTV in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $41.0 on 06/08/2026
- Josh Schimmer from Cantor Fitzgerald set a target price of $40.0 on 05/11/2026
- Martin Fan from Wedbush set a target price of $40.0 on 05/11/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $35.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
